These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24830507)

  • 1. Multivalent comb-type aptamer-siRNA conjugates for efficient and selective intracellular delivery.
    Yoo H; Jung H; Kim SA; Mok H
    Chem Commun (Camb); 2014 Jun; 50(51):6765-7. PubMed ID: 24830507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivalent Aptamer-RNA Conjugates for Simple and Efficient Delivery of Doxorubicin/siRNA into Multidrug-Resistant Cells.
    Jeong H; Lee SH; Hwang Y; Yoo H; Jung H; Kim SH; Mok H
    Macromol Biosci; 2017 Apr; 17(4):. PubMed ID: 27863037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
    Li X; Zhao Q; Qiu L
    J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aptamer mediated siRNA delivery.
    Chu TC; Twu KY; Ellington AD; Levy M
    Nucleic Acids Res; 2006 Jun; 34(10):e73. PubMed ID: 16740739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted siRNA delivery using aptamer-siRNA chimeras and aptamer-conjugated nanoparticles.
    Sivakumar P; Kim S; Kang HC; Shim MS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 May; 11(3):e1543. PubMed ID: 30070426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide-Aptamer Coassembly Nanocarrier for Cancer Therapy.
    Ma Y; Li W; Zhou Z; Qin X; Wang D; Gao Y; Yu Z; Yin F; Li Z
    Bioconjug Chem; 2019 Mar; 30(3):536-540. PubMed ID: 30702869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Characterization of Aptamer-Targeted SNALPs for the Delivery of siRNA.
    Wilner SE; Levy M
    Methods Mol Biol; 2016; 1380():211-24. PubMed ID: 26552829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advance in the study of targeting delivery system for siRNA mediated by aptamers].
    Wang XL; Wang QQ; Song HF
    Yao Xue Xue Bao; 2012 Jul; 47(7):850-5. PubMed ID: 22993847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What potential do aptamers hold in therapeutic delivery?
    Shigdar S
    Ther Deliv; 2017 Feb; 8(2):53-55. PubMed ID: 28088878
    [No Abstract]   [Full Text] [Related]  

  • 10. Reductive nanocomplex encapsulation of cRGD-siRNA conjugates for enhanced targeting to cancer cells.
    Zhou Z; Liu S; Zhang Y; Yang X; Ma Y; Guan Z; Wu Y; Zhang L; Yang Z
    Int J Nanomedicine; 2017; 12():7255-7272. PubMed ID: 29042774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current progress on aptamer-targeted oligonucleotide therapeutics.
    Dassie JP; Giangrande PH
    Ther Deliv; 2013 Dec; 4(12):1527-46. PubMed ID: 24304250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient and targeted delivery of siRNA in vivo.
    Shim MS; Kwon YJ
    FEBS J; 2010 Dec; 277(23):4814-27. PubMed ID: 21078116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and Preparation of Aptamer-siRNA Chimeras (AsiCs) for Targeted Cancer Therapy.
    Kruspe S; Giangrande PH
    Methods Mol Biol; 2017; 1632():175-186. PubMed ID: 28730439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small interfering RNA nunchucks with a hydrophobic linker for efficient intracellular delivery.
    Jo SD; Kim JS; Joe CO; Mok H; Nam YS
    Macromol Biosci; 2014 Feb; 14(2):195-201. PubMed ID: 24106091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods for assembling B-cell lymphoma specific and internalizing aptamer-siRNA nanoparticles via the sticky bridge.
    Zhou J; Rossi JJ; Shum KT
    Methods Mol Biol; 2015; 1297():169-85. PubMed ID: 25896003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SiRNA-phospholipid conjugates for gene and drug delivery in cancer treatment.
    Liu H; Li Y; Mozhi A; Zhang L; Liu Y; Xu X; Xing J; Liang X; Ma G; Yang J; Zhang X
    Biomaterials; 2014 Aug; 35(24):6519-33. PubMed ID: 24797882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporation of biaryl units into the 5' and 3' ends of sense and antisense strands of siRNA duplexes improves strand selectivity and nuclease resistance.
    Yoshikawa K; Ogata A; Matsuda C; Kohara M; Iba H; Kitade Y; Ueno Y
    Bioconjug Chem; 2011 Jan; 22(1):42-9. PubMed ID: 21141919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Types of non-viral delivery systems of small interfering RNA].
    Glebova KV; Marakhonov AV; Baranova AV; Skoblov MIu
    Mol Biol (Mosk); 2012; 46(3):387-401. PubMed ID: 22888629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle-conjugated aptamer targeting hnRNP A2/B1 can recognize multiple tumor cells and inhibit their proliferation.
    Li H; Guo L; Huang A; Xu H; Liu X; Ding H; Dong J; Li J; Wang C; Su X; Ge X; Sun L; Bai C; Shen X; Fang T; Li Z; Zhou Y; Zhan L; Li S; Xie J; Shao N
    Biomaterials; 2015 Sep; 63():168-76. PubMed ID: 26107993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of HIV-1 protease expression in T cells owing to DNA aptamer-mediated specific delivery of siRNA.
    Zhu Q; Shibata T; Kabashima T; Kai M
    Eur J Med Chem; 2012 Oct; 56():396-9. PubMed ID: 22907035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.